Elisabeth Genestin
- Neurology top 5%
- Neuroblastoma Research and Treatments 2
- Oncology top 10%
- Epidemiology top 10%
- Neuroendocrine Tumor Research Advances 2
-
- Gastroesophageal reflux and treatments 2
-
- Clinical Nutrition and Gastroenterology 3
-
- Diverticular Disease and Complications 2
- Enhanced Recovery After Surgery 1
-
- Inflammatory Bowel Disease 2
-
- Abdominal Surgery and Complications 1
- Co-authors
- Michel DucreuxPhilippe RuszniewskiRaymond JianJoëlle BlumbergD CloarecJ L DupasP. RougierHervé Gouérou
- Cited by
- NeurologyOncologyEpidemiology
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
Elisabeth Genestin
10 papers receiving 360 citations
Peers
Comparison fields: 5 of 34
- Neurology 247
- Oncology 264
- Epidemiology 305
- Gastroenterology 29
- Endocrinology, Diabetes and Metabolism 36
Countries citing papers authored by Elisabeth Genestin
This map shows the geographic impact of Elisabeth Genestin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Genestin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Genestin more than expected).
Fields of papers citing papers by Elisabeth Genestin
This network shows the impact of papers produced by Elisabeth Genestin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Genestin. The network helps show where Elisabeth Genestin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisabeth Genestin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 16 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 15 | |
| 6 | Abstract 16127: Effect of REGN727/SAR236553 Anti-Proprotein Convertase Subtilisin/Kexin Type 9 Fully Human Monoclonal Antibody in Patients with Elevated Triglycerides/Low High-Density Lipoprotein Cholesterol: Data from Three Phase 2 Studies (NCT:01266876; 01288469; 01288443) | 2012 | 2 |
| 7 | 2011 | 12 | |
| 8 | 2005 | 9 | |
| 9 | 2000 | 154 | |
| 10 | 1996 | 159 | |
| 11 | [Partial regression of a desmoid tumor after prolonged treatment with lanreotide]. | 1995 | 1 |
About Elisabeth Genestin
Elisabeth Genestin is a scholar working on Gastroenterology, Nutrition and Dietetics and Neurology, having authored 11 papers that have together received 378 indexed citations. Recurring topics across this work include Clinical Nutrition and Gastroenterology (3 papers), Gastroesophageal reflux and treatments (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Neuroblastoma Research and Treatments (2 papers), Diverticular Disease and Complications (2 papers), Inflammatory Bowel Disease (2 papers), Abdominal Surgery and Complications (1 paper) and Enhanced Recovery After Surgery (1 paper). The work is most often cited by research in Neurology (247 citations), Oncology (264 citations) and Epidemiology (305 citations). Elisabeth Genestin has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Michel Ducreux, Philippe Ruszniewski, Raymond Jian, Joëlle Blumberg, D Cloarec, J L Dupas, P. Rougier, Hervé Gouérou, Jean‐Alain Chayvialle and H Michel. Their work appears in journals such as Circulation, Gut and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.